Abstract: Various aspects described herein relate to a system that utilized deep learning and neural networks to estimate/predict an amount of natural resource production in a well given a set of parameters indicative of physical changes to the well. In one aspect, a virtual flow meter includes memory having computer-readable instructions stored therein and one or more processors configured to execute the computer-readable instructions to receive one or more input parameters indicative of physical changes to at least one well; apply the one or more input parameters to a trained neural network architecture; and determine one or more outputs of the trained neural network architecture, the one or more outputs corresponding to predicted fluid output of the at least one well.

Abstract: Various aspects described herein relate to a system that utilized deep learning and neural networks to estimate/predict an amount of natural resource production in a well given a set of parameters indicative of physical changes to the well. In one aspect, a virtual flow meter includes memory having computer-readable instructions stored therein and one or more processors configured to execute the computer-readable instructions to receive one or more input parameters indicative of physical changes to at least one well; apply the one or more input parameters to a trained neural network architecture; and determine one or more outputs of the trained neural network architecture, the one or more outputs corresponding to predicted fluid output of the at least one well.

Abstract: This invention relates to compositions for the delivery of substituted naphthyl indole derivatives as well as to the use of these compositions and methods for treating disease.

Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.

Abstract: The present invention relates to solid dosage formulations that include ER?-selective ligands that contain benzoxazole, and processes for manufacture of said formulations, more particularly to novel formulations and processes for manufacture of formulations containing the ER?-selective ligand, ERB-041.

Abstract: This invention relates to novel extended release pharmaceutical dosage forms for orally delivering drugs to mammals, e.g., humans. More particularly, this invention concerns novel dosage forms of water soluble drugs such as venlafaxine, enantiomeric (R or S) forms of venlafaxine, metabolites of venlafaxine such as O-desmethyl venlafaxine (ODV) or enantiomeric (R or S) forms of said metabolites which dosage forms have an extended release profile when taken orally. This invention also provides processes for preparing such dosage forms and methods of using them.

Abstract: A novel salt of O-desmethyl venlafaxine is provided, O-desmethylvenlafaxine succinate. Pharmaceutical compositions, dosage forms and methods of use are also provided.

Abstract: The disclosed mass flow transducer is of the type including a balanced bridge comprising two, substantially identical, thermal elements forming two sides of the bridge between the top and the bottom of the bridge, the two elements being adapted to be positioned in two regions of a laminar flow tube in a symmetrical tandem arrangement so as to sense flow through the tube, one element being upstream from the other. The preferred transducer includes control means for monitoring the voltage at the top and bottom of the bridge and monitoring the current required to maintain the node between the thermal elements at virtual ground.